br+/nad with tirzepatide GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome Tirzepatide vs Tirzepatide/NAD+ | Weight

Medially authored by Joshua Silva, MD, medical director of Potere Health MD

This is classic hyperesthesia and is the most commonly reported symptom among retatrutide users experiencing skin sensitivity

Stop tirzepatide and contact your healthcare provider immediately if you experience severe abdominal pain that does not resolve (possible pancreatitis), vision changes, rapid heartbeat, signs of allergic reaction (rash, difficulty breathing, facial swelling), or symptoms of thyroid issues (lump or swelling in the neck, difficulty swallowing, persistent hoarseness)

Its crucial for individuals on GLP-1 medications to monitor their nutritional intake closely and consider supplementation under medical guidance to avoid deficiencies

If you take oral contraceptives, antibiotics, or other time-sensitive medications, discuss timing with your prescriber

Survey data summarized by the Kinsey Institute highlight how GLP-1 medications are reshaping body image and intimacy patterns across users, as outlined in sexual wellness trends